Imaging of Lungs With a New Type of Magnetic Resonance Imaging (MRI) Called UTE (Ultrashort Echo Time)



Status:Recruiting
Conditions:Pulmonary
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:5 - Any
Updated:6/7/2018
Start Date:October 2015
End Date:December 2021
Contact:Erin Watters
Email:Erin.Watters@cchmc.org
Phone:513-803-7024

Use our guide to learn which trials are right for you!

Lung Imaging With Ultra-short Echo Time MRI

This research study has 2 purposes:

1. To learn about new ways to use Magnetic Resonance Imaging (MRI) to take clearer pictures
of the lungs. A type of MRI called Ultra Short Echo Time (UTE) will be used as well as
traditional MRI.

2. To collect images and health information about lungs that have different kinds of lung
diseases to compare to healthy lungs. This collection will help researchers and
clinicians to better understand lung variations in health and disease.

This study will involve one MRI session that will take about 10 to 30 minutes and for some
participants a breathing test that measures how well the lungs are working. This test is
called spirometry.

Interstitial, obstructive, and rare lung diseases are pulmonary disorders that comprise more
than 300 disease entities that are poorly understood, diagnosed, and treated. X-ray computed
tomography (CT) is the imaging gold standard and the current clinical practice for imaging
lung structure and function of patients. Recent advances in magnetic resonance imaging (MRI)
pulse sequences and hardware with ultra short echo times (UTE) have enabled MRI of lung
anatomy nearly comparable to CT without the risk of ionizing radiation.

The overreaching goals of this study are:

1. to allow for technical development and validation of UTE MRI sequences as an imaging
alternative to CT as well as a future diagnostic tool, and

2. to allow for preliminary UTE data generation for healthy and various disease
populations. We anticipate this as being particularly important for data on children
where variability is greater due to normal variations in size, age and maturity as well
as distinctive differences in expression of lung diseases in pediatrics versus adult
populations.

This is a prospective, controlled study for technical development and validation of UTE MRI
techniques with normal and disease cohorts. This study will use the standard MRI hardware
(FDA approved coils and magnet) but will be developing and refining techniques used in the
MRI sequences to obtain UTE images. This refinement includes varying the MRI settings to
maximize image signal, to control image contrast, and to develop the software needed to
acquire more specialized images for the purpose of improved imaging of the lungs. The data
will also be used to collect normative data for comparison with lung pathologies.

Subjects may enroll more than once (with separate consent). For these subjects the MRI
information may be used to generate data for in-subject temporal variability in both healthy
controls and disease groups.

Inclusion Criteria:

- Signed informed consent or Parental Permission

- Age ≥ 5 years

- Willing and able to comply with MRI instructions

Exclusion Criteria:

- History of any comorbidity reviewed at the Screening Visit that, in the opinion of the
investigator, might confound the results of the study or pose an additional risk to
the subject.

- Standard MRI exclusion criteria as set forth by the Cincinnati Children's Hospital
Radiology Department and Imaging Research Center.

- Pregnancy
We found this trial at
1
site
3333 Burnet Avenue # Mlc3008
Cincinnati, Ohio 45229
 1-513-636-4200 
Principal Investigator: Zackary Cleveland, PhD
Phone: 513-803-7024
Cincinnati Children's Hospital Medical Center Patients and families from across the region and around the...
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials